Our platform is designed to scale with you.
About Locke Bio
Locke Bio is a digital health platform company which helps brands launch a fully integrated, white-labeled telehealth service which includes: a customized patient intake approved by board certified physicians, personalized telemedicine consultations, e-commerce payment processing, advanced marketing analytics, and a seamlessly integrated pharmacy and provider network.
Locke Bio aims to bridge the gap between e-commerce and pharma to transform the entire drug distribution industry. Our platform enables patients to receive the best level of care through world class digital healthcare services.
Locke Bio was founded in 2019, initially as a conglomerate of direct-to-consumer digital prescription brands in the US, Canada, and Brazil. That’s when we realized how difficult, manual, and expensive it was to set up a new brand each time. Our technology platform today reflects our learnings and experiences from launching and growing multiple successful prescription brands. We’ve formed partnerships with scalable physician, pharmacy, and payments networks in each country that we operate in, so we can help you solve the biggest challenges in launching your brand.
“In 2023, there is no reason why telehealth and prescription drugs shouldn’t be as easy to navigate as e-commerce.”
CEO at Locke Bio
“Online prescriptions should be as easily customizable as buying items online. We strive to match the level of personalization offered by e-commerce platforms.
Lead Developer at Locke Bio